These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18089831)

  • 1. Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer.
    Pereira-Faca SR; Kuick R; Puravs E; Zhang Q; Krasnoselsky AL; Phanstiel D; Qiu J; Misek DE; Hinderer R; Tammemagi M; Landi MT; Caporaso N; Pfeiffer R; Edelstein C; Goodman G; Barnett M; Thornquist M; Brenner D; Hanash SM
    Cancer Res; 2007 Dec; 67(24):12000-6. PubMed ID: 18089831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera.
    Qiu J; Choi G; Li L; Wang H; Pitteri SJ; Pereira-Faca SR; Krasnoselsky AL; Randolph TW; Omenn GS; Edelstein C; Barnett MJ; Thornquist MD; Goodman GE; Brenner DE; Feng Z; Hanash SM
    J Clin Oncol; 2008 Nov; 26(31):5060-6. PubMed ID: 18794547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer.
    Brichory F; Beer D; Le Naour F; Giordano T; Hanash S
    Cancer Res; 2001 Nov; 61(21):7908-12. PubMed ID: 11691811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of tumor antigens that elicit a humoral immune response in the sera of Chinese esophageal squamous cell carcinoma patients by modified serological proteome analysis.
    Gao H; Zheng Z; Mao Y; Wang W; Qiao Y; Zhou L; Liu F; He H; Zhao X
    Cancer Lett; 2014 Mar; 344(1):54-61. PubMed ID: 24157810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response.
    Madoz-Gúrpide J; Kuick R; Wang H; Misek DE; Hanash SM
    Mol Cell Proteomics; 2008 Feb; 7(2):268-81. PubMed ID: 17916591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer.
    Brichory FM; Misek DE; Yim AM; Krause MC; Giordano TJ; Beer DG; Hanash SM
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9824-9. PubMed ID: 11504947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer.
    Hong SH; Misek DE; Wang H; Puravs E; Giordano TJ; Greenson JK; Brenner DE; Simeone DM; Logsdon CD; Hanash SM
    Cancer Res; 2004 Aug; 64(15):5504-10. PubMed ID: 15289361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies against tumor-associated antigens in the early detection of lung cancer.
    Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY
    Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma.
    Chen G; Wang X; Yu J; Varambally S; Yu J; Thomas DG; Lin MY; Vishnu P; Wang Z; Wang R; Fielhauer J; Ghosh D; Giordano TJ; Giacherio D; Chang AC; Orringer MB; El-Hefnawy T; Bigbee WL; Beer DG; Chinnaiyan AM
    Cancer Res; 2007 Apr; 67(7):3461-7. PubMed ID: 17409457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
    Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
    Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular profiling of the immune response in colon cancer using protein microarrays: occurrence of autoantibodies to ubiquitin C-terminal hydrolase L3.
    Nam MJ; Madoz-Gurpide J; Wang H; Lescure P; Schmalbach CE; Zhao R; Misek DE; Kuick R; Brenner DE; Hanash SM
    Proteomics; 2003 Nov; 3(11):2108-15. PubMed ID: 14595809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules.
    Wang J; Shivakumar S; Barker K; Tang Y; Wallstrom G; Park JG; Tsay JC; Pass HI; Rom WN; LaBaer J; Qiu J
    J Thorac Oncol; 2016 Mar; 11(3):334-45. PubMed ID: 26896032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Diagnostic Model With IgM Autoantibodies and Carcinoembryonic Antigen for Early Detection of Lung Adenocarcinoma.
    Zhang X; Li J; Wang Y; Liu M; Liu F; Zhang X; Pei L; Wang T; Jiang D; Wang X; Zhang J; Dai L
    Front Immunol; 2021; 12():728853. PubMed ID: 35140701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal serum autoantibody repertoire profiling identifies surgery-associated biomarkers in lung adenocarcinoma.
    Li Y; Li CQ; Guo SJ; Guo W; Jiang HW; Li HC; Tao SC
    EBioMedicine; 2020 Mar; 53():102674. PubMed ID: 32113159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer.
    Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY
    Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovering novel lung cancer associated antigens and the utilization of their autoantibodies in detection of lung cancer.
    Pei L; Liu H; Ouyang S; Zhao C; Liu M; Wang T; Wang P; Ye H; Wang K; Song C; Zhang J; Dai L
    Immunobiology; 2020 Mar; 225(2):151891. PubMed ID: 31839396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum antibodies to retinal antigens in lung cancer and sarcoidosis.
    Jankowska R; Witkowska D; Porebska I; Kuropatwa M; Kurowska E; Gorczyca WA
    Pathobiology; 2004; 71(6):323-8. PubMed ID: 15627843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquisition of useful sero-diagnostic autoantibodies using the same patients'sera and tumor tissues.
    Kobayashi M; Nagashio R; Ryuge S; Murakami Y; Yanagita K; Nakashima H; Matsumoto T; Jiang SX; Saegusa M; Satoh Y; Masuda N; Sato Y
    Biomed Res; 2014; 35(2):133-43. PubMed ID: 24759181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Combination of IgA and IgG autoantibodies against Transcriptional Intermediary Factor-1γ contributes to the early diagnosis of Lung Cancer.
    Yu L; Lin X; Zhang L; Wu Q; Zhang S; Chen D; Pan X; Huang Y
    Int J Med Sci; 2020; 17(11):1561-1568. PubMed ID: 32669959
    [No Abstract]   [Full Text] [Related]  

  • 20. [Proteome analysis of autoantibodies in sera of patients with cancer].
    Ueda K
    Rinsho Byori; 2005 May; 53(5):437-45. PubMed ID: 15966408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.